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Abstract 
Södersten F. 2006.  Cartilage Oligomeric Matrix Protein (COMP), Thrombospondin-4 
(TSP-4) and type I and III Collagens in tendon – An immunohistochemical and biochemical 
study. 
Doctoral thesis. ISSN 1652-6880, ISBN 91-576-7143-5 
 
Injury to digital flexor tendons leading to partial or total rupture is a common cause of 
lameness in athletic horses. Degeneration to the tendon extracellular matrix (ECM) often 
precedes rupture and a high cyclic load is most likely an important factor explaining its 
high incidence in racing horses. 
Tendon is composed of tenocytes that produce and support an abundant ECM responsible 
for the physical properties of the tendon. Type I collagen, the most abundant protein in the 
ECM, forms long fibrils and is oriented along the tensional axis of the tendon. Other matrix 
molecules include type III collagen, proteoglycans, glycoproteins (COMP and TSP-4). 
These molecules contribute to the strength of the tendon and are involved in regulating 
extracellular growth of the collagen fibrils. 
The ultrastructural distributions of COMP were delineated with high immunolabeling in 
healthy three-year-old horses. In the same material, collagen fibril size and the relative 
distribution of thin, medium and thick fibrils were examined and the highest levels of thin 
fibrils were found in the three-year-old horses. Achilles tendons from rats were analysed 
and an active-related decrease in COMP immunolabelling was found. The 
immunolocalization of TSP-4 was clearly elevated in the pericellular compartment. In 
injured equine tendons, immunolabelling of COMP and type III collagen was present in all 
repair structures, described as organized and disorganized fibroblastic. TSP-4 was purified 
from equine tendon and a heterooligomer between COMP and TSP-4 was displayed. 
This Thesis shows that COMP increases in equine tendons during skeletal maturation and is 
related to greater amounts of thin fibrils. Furthermore, COMP is present in tendon repair 
tissue and. these findings indicate a role during repair/remodelling where the fibrils are 
newly synthesised. The decrease in COMP found in active rat tendons can be caused by 
activity-induced degradation. The heterooligomers of COMP and TSP-4 and the 
immunolocalization of TSP-4 indicate a function as an adhesion and/or signal molecule 
between the cell membrane and the extracellular matrix. These results indicate that COMP 
is involved in activity and aging processes, in repair processes in combination with type III 
collagen, and in heterooligomer formation with TSP-4 in equine tendon. 
Keywords: Tendon, extracellular matrix, COMP, TSP-4, equine, activity, ageing, type I and 
III collagen. 
 
Author’s address: Fredrik Södersten, Department of Biomedical Science and Veterinary 
Public Health, Division of Pathology, Pharmacology and Toxicology Swedish University of 
Agricultural Sciences (SLU), P.O. Box 7028, SE-75007 Uppsala, Sweden.   6
   7 
Contents 
Introduction,  11 
Background,  11 
Anatomy,  11 
The tissue,  13 
Type I collagen,  13 
Type III collagen,  14 
Type V collagen,  15 
Proteoglycans (PGs),  15 
COMP,  16 
TSP-4,  16 
Matrix metalloproteinases,  16 
Molecular biology,  17 
Tendon injuries,  18 
Treatment of equine tendon injury,  20 
Aims of the thesis,  23 
Hypothesis,  23 
Materials and methods,  24 
Results,  26 
General discussion,  28 
Conclusions,  31 
Future perspectives,  31 
References,  32 
Financial support  41 
Acknowledgements,  42   8
   9 
Appendix 
Papers I-IV 
This thesis is based on the following papers which are referred to in the text by the 
Roman numerals as set below: 
 
I.  Södersten, F., Ekman, S., Eloranta, M-L., Heinegård, D., Dudhia, 
J., Hultenby, K. (2005) Ultrastructural immunolocalization of 
cartilage oligomeric matrix protein (COMP) in relation to collagen 
fibrils in the equine tendon. Matrix Biology 24, 376-385 
 
II.  Södersten, F., Ekman, S., Schmitz, M., Paulsson, M., Zaucke, F. 
(2006) Thrombosponding-4 and cartilage oligomeric matrix protein 
form heterooligomers in equine tendon. Connective Tissue 
Research 47, 85-91 
 
III.  Södersten, F., Ekman, S., Niehoff, A., Zaucke, F., Heinegård, D., 
Hultenby, K. Ultrastrcutural immunolocalization of Cartilage 
oligomeric matrix protein (COMP), Thrombospondin-4 (TSP-4) 
and collagen fibril size in the rodent Achilles tendon in relation to 
exercise. In manuscript.   
 
IV.  Södersten, F., Hultenby, K., Heinegård, D., Johnston C., Ekman, S. 
Immunolocalization of collagens (I and III), and cartilage 
oligomeric matrix protein (COMP) in normal and injured 
superficial digital flexor tendon. In manuscript. 
 
The papers presented are printed with the kind permission from the journals 
concerned.   10
Abbreviations 
BAPN             beta  amino  propionitril  fumarate 
CDET          common  digital  extensor  tendon 
COMP           cartilage  oligomeric  matrix  protein 
DDFT          deep  digital  flexor  tendon 
DEAE          diethylamino  ethanol 
DIG           digoxigenin 
ECM            extracellular  matrix 
EDTA          ethylenediaminetetraacetic  acid 
FGF           fibroblast  growth  factor 
GAG            glucosaminoglycans 
H & E              h a e m a t o x y l i n   e o s i n  
I G F              i n s u l i n e - l i k e   g r o w t h   f a c t o r  
MED            multiple  epiphyseal  dysplasia 
MS MALDI-TOF    mass-spectrometry  matrix-assisted laser desorption / 
ionisation time of flight  
M M P             m a t r i x   m e t a l l o   p r o t e i n a s e  
NSAID           non-steroidal  anti  inflammatory  drug 
P G              p r o t e o g l y c a n  
PSACH           pseudoachondroplasia 
PS-GAG          polysulphated  glycosaminoglycans 
SDFT            superficial  digital  flexor  tendon 
SDS-PAGE    sodium dodecyl sulphate polyacrylamide gel 
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S L              s u s p e n s o r y   l i g a m e n t  
TIMP            tissue  inhibitors  of  metalloproteinase 
TSP           thrombospondin 
U B M             u r i n a r y   b l a d d e r   m a t r i x  
VEGF          vascular  endothelial  growth  factor   11 
Introduction 
Background 
Tendons and ligaments are fibrous structures prone to injury in athletic horses. A 
survey in Britain covering thoroughbred horses, competing in both flat racing and 
national hunt, found the most common cause of lameness was damage to the 
flexor tendons and suspensory ligaments (Williams et al., 2001). These injuries 
varied from mild strains to partial or total rupture most often affecting the 
superficial digital flexor tendon (SDFT) in the forelimb. Injuries in tendons 
usually require long rehabilitation and recurrence is common (Goodship, Birch & 
Wilson, 1994; Dyson, 2004; Davis & Smith, 2006). Prognosis is often based on 
ultrasound and clinical findings and the severity of the initial injury is naturally 
significant in this. Repair should be monitored with repeated ultrasound scanning 
of the tendon to avoid early setbacks in rehabilitation (Dyson, 2004). In trotters, 
the suspensory ligament (SL) (hind limbs) is more affected (Goodship et al., 
1994). Although the suspensory ligaments are to some extent muscular, their 
function is similar as the flexor tendons and the prognosis and treatment of such 
injuries is comparable (Goodship et al., 1994). Common treatment forms involve 
rest followed by slowly increasing, controlled exercise. There are several methods 
described involving injecting various substances in the tendon to enhance healing. 
These methods however, are based on empirical knowledge and there are few 
scientific reports in the literature (Dyson, 2004; Davis & Smith, 2006). Increased 
understanding of the biochemical and morphological response in the tendon to 
various tensional and compressive loads is important in order to understand the 
pathogenesis of tendon injury and rupture. Changes to the structural integrity in 
the extracellular matrix of the tendon will differ between anabolic (healing and 
repair) and catabolic (degeneration) processes. Data on these molecular changes in 
relation to exercise induced tendon injuries can result in candidate molecular 
markers for tendon homeostasis. 
 
Anatomy 
Tendons and ligaments are important structures in the locomotor apparatus that 
transmits high force between muscles and bones. In addition, the equine flexor 
tendons and SL are loaded eccentrically during the weight bearing part of the 
stride (Stephens, Nunamaker & Butterweck, 1989; Riemersma et al., 1996). The 
anatomical counterpart of the SDFT is the common digital extensor tendon 
(CDET), which is loaded only with muscular contraction. The CDET acts as a 
positional tendon extending the limb before it hits the ground during the stride, 
and is rarely injured due to overuse (Alexander, 1988; Kear & Smith, 1975). 
Moreover, the CDET responds to increased load or activity with lateral growth. 
The flexor tendons however, do not have the same capability to react and only 
minor changes in the width have been recorded in similar conditions (Birch et al., 
1999b). 
In particular, the SDFT stores kinetic energy through its elastic properties. Most of 
this energy is returned in the later phase of the stride improving the efficiency of movement. The lost kinetic energy is transformed into heat (Goodship et al., 
1994). 
The SDFT originates at the end of the superficial digital flexor muscle (musculus 
flexor digitorum superficiali,), a rather small muscle, originating on the medial 
epicondyle of humerus. The digital flexor muscles contribute little or minimal to 
the normal movement, but are important in damping high-frequency vibrations in 
the limb during high-speed galloping (Wilson et al., 2001). The muscle has a 
second origin directly attached to the caudal part of the radius with a fibrous band 
having minor contractive capabilities. This band fuses to the proximal part of the 
tendon just above the carpus. In the carpal channel, the tendon is invaginated and 
surrounded by synovial fluid (decreasing the friction over the joint). It runs 
superficially under the skin along the metacarpal bone where it is enclosed only by 
a loose network of connective tissue. Proximal to the fetlock, the SDFT passes 
into another tendon sheet where it envelops the deep digital flexor tendon 
(DDFT), then dividing and continuing as two branches each inserted on the 
proximal lateral eminences of the middle phalanx. Above the fetlock, the DDFT 
and SL are located between the SDFT and the limb (Fig. 1). Below the fetlock, the 
DDFT continues to the distal phalanx, where it inserts and the SL attaches laterally 
on the sesamoidean bones and continues dorsally, fusing to the long extensor 
tendon (Sisson & Grossman, 1953). 
The extended length of the SDFT and that it passes two major joints, adds 
shearing and compressive forces to parts of the tendon. In these areas, the 
composition of the tendon is different than regions experiencing predominantly 
























Figure 1. Schematic, anatomical drawing displaying the weight bearing tendons 
in the distal front limb. Superficial Digital Flexor Tendon (SDFT), Deep Digital 
Flexor Tendon (DDFT), Suspensory Ligament (SL). 
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The tissue 
Tendons consist of relatively few cells (tenocytes) that produce, support and 
assemble several extracellular structural proteins, all of which contribute to the 
properties of the tendon. Of these, strength and elasticity are the most important. 
The most prominent extracellular matrix (ECM) protein is type I collagen, forming 
fibrils (Fig. 2). There are other structural molecules between the collagen fibrils 
(Jozsa & Kannus 1997a; rev Wang, 2006) including proteoglycans (such as 
aggrecan, versican, lumican, decorin, biglycan, fibromodulin) glycoproteins 
(COMP, TSP-4) and other proteins (collagen type III, V, IX, XI, XII, XIV). The 
cells also release proteolytic compounds and enzymes such as matrix 
metalloproteinase (MMP:s). Their main purpose is to degrade worn out 
components that are replaced by new tissue within the ECM. However, MMPs can 
be released by a stressed or damaged cell starting an uncontrolled degradation of 
the ECM (Kjaer et al., 2005; Sharma & Maffulli, 2005). 
 
Type I collagen 
The major protein in tendon ECM (70-80 % of the dry weight) is type I collagen, a 
300 nm long (1.5 nm wide) triple-stranded helical molecule (tropocollagen) that 
merge and form long thick fibrils (mm long, up to 300 nm wide) (Fig. 2) (Kadler 
et al 1996).  
 
 















Figure 2. Illustration of the different structures/levels present in the tendon.  
a)  Transverse section of tendon with fascicles (fibrebundles) separated by thin 
endotenon. 
b)  Fibre with striated collagen fibrils. 
c)  Collagen fibril with characteristic dark and bright striation with 67 nm 
periodicity. 
d)  Tropocollagen assembled to a fibril in a staggered pattern. 
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The type of collagen is determined by the type of polypeptide chains incorporated 
into the triple helix. In type I collagen, there are two α1(1) chains and one α2(1) 
(Kadler et al 1996). Before the triple-helix formation proline- and lysine-residues 
within each chain are hydroxylated. These modified amino residues 
(hydroxylysine and hydroxyproline) are necessary in the later extracellular 
formation of covalent cross-links within and between the tropocollagen molecules 
(Myllyharju, 2003). With advancing age nonenzymic glycation with reducing 
sugars from circulation adds cross-links making the fibril more resistant to 
degradation. The ultrastructural cross-striation pattern with 67 nm periodicity 
present in collagen fibrils is a result of a staggered array of the tropocollagen (Fig. 
2 and 3b) (rev Kadler et al 1996; Orgel et al 2006). On light microscopic 
examination, the collagen fibrils appear in a wavy pattern that is called crimp (Fig. 
3a). When the tendon is loaded, the crimp is stretched and the fibrils are aligned. 
The stretching of the crimp waves is responsible for approximately 1-2 percent of 
extension that takes place during loading (O’Brien, 1992). When the tendon is 
unloaded, the crimp reappears and this is, of course, an important component in 
the elastic properties that the tendon possesses. The collagen fibrils form fibres, 
and fibre bundles (fascicles) that are arranged longitudinally in the direction of the 
tensional load. The fascicles are surrounded with a thin layer of loose connective 
tissue also containing vessels and nerves. This loose connective tissue allows 
limited sliding between the fascicles, which adds to the elasticity of the tendon.  
















Type III collagen 
Type III collagen is present to some extent in normal tendon. It is found mainly in 
the endotenon surrounding the type I collagen fibre bundles (Benjamin & Ralphs, 
1997, rev Abrahamson, 1991) but also incorporated in the fibril structure where it 
is believed to inhibit lateral growth of the type I fibril (Benjamin & Ralphs, 1997; 
Birk & Mayne, 1997). Type III collagen is, as with type I collagen, fibrillar in 
basic structure. The fibrils of type III collagen have a generally thinner diameter 
compared with type I collagen fibrils and the tropocollagen contains three α1(3) 
chains (Lapiere et al, 1977; rev Kadler et al 1996). In the early repair of the 
injured tendon, type III collagen fibrils are quickly synthesized to restore some 
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strength and elasticity (Williams et al., 1984; Dahlgren, Brower-Toland & Nixon, 
2005). However, the fibrils do not have the same tensile strength quality as type I 
collagen and so lack the functional properties needed in a tendon experiencing 
maximal load. The repair processes continues with type III fibrils slowly being 
replaced by type I collagen fibrils in an attempt to normalize the properties of the 
tendon (Williams, McCullagh & Silver 1984; Dahlgren, Brower-Toland & Nixon, 
2005). 
In studies on newly ruptured human Achilles tendons, higher levels of type III 
collagen were found in the area surrounding the rupture (Eriksen et al., 2002). In 
clinically non-lame horses, macroscopic and microscopic changes have been 
found in flexor tendons. These tendon changes showed increased levels of type III 
collagen compared to morphologically normal tendons (Birch, Bailey, & 
Goodship, 1998). 
 
Type V collagen 
Type V collagen, another fibril forming collagen, is found in small amounts inside 
the fascicles and in the endotenon. Type V collagen binds to type I collagen and 
regulates the lateral growth of the fibril. In tendons from rabbit, type V collagen 
has been linked to high amount of thin fibrils, suggesting inhibition of fibril 
assembly (Dressler et al., 2002). Deficiencies in type V collagen (genetic 




The tendon also contains different proteoglycans, which are large molecules 
consisting of a protein core (backbone) that attach glycoseaminoglycans (GAGs) 
groups. GAGs are long unbranched polysaccharides made of repeating units 
containing an amino sugar derivative. The PGs are negatively charged, attracting 
positive ions and water, which are important for the extracellular matrix. Versican 
and aggrecan are two large PGs, with hydrophilic properties responsible for 
holding water in the tendon (rev Abrahamson et al., 1991; Benjamin and Ralphs 
1997). 
Decorin, biglycan, fibromodulin are three small proteoglycans found in the 
tendon. They contain one or two GAG-side chains, are collagen binding, act as 
regulators of the fibrillogenesis and also interact with collagen and other 
macromolecules (Watanabe et al., 2005; Zhang et al., 2006). Fibromodulin-
deficient mice were characterized by irregular and disorganized type I collagen 
fibre bundles (Svensson, Oldberg & Heinegård, 2001). A more irregular and often 
smaller collagen fibril population was also reported in fibromodulin-deficient, 
biglycan-deficient and fibromodulin/biglycan-deficent mice compared to wild 
types (Ameye et al., 2002). 
The expression of proteoglycans in tendon changes with location and type of load. 
An increase of aggrecan is found in parts of the tendon subjected to compression 
load (Vogel et al., 1994). In chronic painful Achilles tendinopathy, an increase in 
the expression of aggrecan and biglycan has also been shown in the area subjected 
to tensional load (Corps et al., 2006), suggesting differences of the ECM between 
normal and injured tendons.   16
 
COMP 
Cartilage Oligomeric Matrix Protein (COMP), also called TSP-5, is a glycosylated 
protein in the thrombospondin family. COMP contains five identical subunits 
(Mörgelin et al., 1992) linked together with a coil in the N-terminal forming a 
five-armed pentamer structure. There are collagen-binding domains on each arm 
(type I and II collagens) allowing a single pentamer to bind to more than one 
collagen molecule at the same time (Rosenberg et al., 1998). COMP, first 
discovered in cartilage (Hedbom et al., 1992), has also been found in tendon 
(DiCesare  et al., 1994) tissue where it is one of the most abundant non-
collagenous proteins. The function of COMP is not fully understood, but it is 
related to fibrillogenesis and binds to several proteoglycans including 
fibromodulin (Hedlund et al., 1994). COMP levels in tendon has been correlated 
to activity (Smith et al., 1997), indicating that COMP is important in the 
physiological adaptation of the connective tissue to increased load. Deletions and 
mutations in the COMP genome are responsible for the inherited diseases 
Pseudoachondroplasia (PSACH) and Multiple epiphyseal dysplasia (MED) 
(Briggs et al., 1995). These conditions result in COMP not being released from the 
cells so the protein is stored within the cytoplasm, which ultimately impairs 
normal cell function (Hecht et al., 1999; Thur et al., 2001; Dinser et al., 2002). 
This results in symptoms of arthritis, deformed bones and laxities in the tendons. 
 
TSP-4 
Thrombospondin-4 (TSP-4) is, like COMP, a glycosylated protein in the 
thrombospondin family. Structurally, it is similar to COMP having five subunits 
that are linked together in the N-terminal. Each subunit that forms an arm in the 
pentamer has collagen binding domains. Unlike COMP, TSP-4 has a heparin-
binding domain in the N-terminal allowing it to bind to cell surfaces (Lawler et al., 
1995). TSP-4 has been identified in tendon (Hauser et al., 1995) and in heart and 
brain during embryogenesis but its ultimate function is not yet known (Lawler et 
al., 1993; Narrouz-Ott et al., 2000). The primary and secondary structural 
resemblance to COMP suggests a similar function involving regulatory action 
during fibrillogenesis. The additional heparin-binding domain indicates that TSP-4 
can act as an interface between extracellular collagen fibrils and the tenocytes. 
 
Matrix metalloproteinases 
Most tissues have periods of normal breakdown in the ECM, during development, 
morphogenesis, resorption and remodelling. MMPs are involved in these 
processes. MMPs are synthesized in the cell and secreted as inactivate pro-
enzymes into the extracellular matrix. The expression of MMPs can be regulated 
by growth factors, hormones and cytokines as well as cellular transformation. 
They have several functions and are divided into type according to the substrate 
they digest, such as interstitial collagenases (MMP-1, 8, and 13), gelatinases 
(MMP-2 and 9), stromelysins (MMP-3, 10 and 11), matrilysins (MMP-7), and 
membrane-type MMPs such as MMP-14. After release, their function is controlled 
by endogenous inhibitors where TIMPs (tissue inhibitors of metalloproteinases) are an important group (rev Nagase & Woessner, 1999). In a study where the 
expression of MMPs and TIMPs was compared between normal, degenerated and 
ruptured human Achilles tendon, MMPs 3 and 7 and TIMPs 2, 3 and 4 were down 
regulated in the ruptured tendons. In addition, there was higher expression of 
MMPs 1, 9, 19 and 25 and TIMP-1 in ruptured tendons compared to normal 
tendon (Jones et al., 2006). In painful but not ruptured tendons, an up regulation 
of MMP-23 and a down regulation of MMPs 3 and 10 and TIMP-3 was found 
(Jones et al., 2006). In another study, MMP activity and their relationship with 
collagen remodelling in tendon pathology was investigated. Briefly, the enzyme 
activity of MMPs 1, 2, 3, 9 and 13, measured in extract from ruptured human 
supraspinatus tendons, was compared to MMP activity in extracts from normal 
supraspinatus tendons and biceps brachii tendons (Riley et al., 2002). In addition, 
collagen denaturation was measured. MMP-1 activity was higher in the ruptured 
tendons where an increased amount of denaturated collagen was also found. But 
the activity of MMP-2 and MMP-3 was lower in the ruptured tendons (Riley et al., 
2002). These findings emphasize the role of MMP during breakdown and turnover 
of the tendon ECM. 
 
Molecular biology 
All these extracellular molecules are synthesised and secreted by relatively few 
cells (tenocytes) located in the area between the fibres with protruding extensions 
into the fibres (Fig. 4). Tenocytes originate in the mesenchymal and have features 






















Figure 4. Schematic figure of the tenocyte during collagen fibril synthesis, with 
additional molecules COMP, TSP-4, heparin and decorin involved in the 
fibrillogenesis/fibrilassembly and linking between the cell and the extracellular 
matrix. 
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They are suggested to be a differentiation of fibrocytes/blasts (Junquiera et al., 
1991; Towler & Gelberman, 2006). Endotenon is comprised of fibrocytes/blasts 
and vessels. They show low metabolic activity in mature tendon, which only 
allows slow and small adjustment of the ECM.The turnover rate of type I collagen 
in the tendon is similar to that in bone. The hydroxylation of proline and lysine 
stabilize the molecule and, accordingly, decrease the turnover rate even more. The 
hydroxylation processes are not evenly distributed in the tendon, hence the 
turnover rate can differ within the tendon (rev Kjaer, 2004).The macromolecular 
and cellular composition of tendon changes with age (Vogel & Koob 1989; Smith 
et al 1997; Birch et al 1999a). The elastic modulus decreases with age and the 
density of tenocytes decreases. The diameters of the collagen fibrils decrease (rev 
Benjamin & Ralphs, 1997) and the amount of proteoglycans and 
glycosaminoglycans (GAGs) in avian tendon increases during maturation and with 
exercise (Yoon et al., 2003). An increase of hydroxylation between the fibrils in 
horses has also been reported with age (Patterson-Kane et al., 1997). Some of 
these changes can be physiological and hence normal in the maturation process, 
but many of the alterations decrease the strength and/or the elasticity of the tendon 
and it is probable that they are more degenerative in nature. 
The cells in the tendon support and produce new extracellular matrix and adapt the 
tendon to load (Langberg et al., 2001; Smith et al., 2002). For example, when 
mechanical activity increases, the flexor tendon does not grow in width in the 
same proportions as muscles do. Instead, ECM composition is altered with a 
change in the collagen fibril structural pattern and macromolecular alteration with 
an increase in the amount of thinner collagen fibrils (Cherdchutham et al., 1999). 
When the tendon is loaded with tensional forces the ECM and the tenocytes within 
is stretched and elongated. Cells can detect mechanical stimuli in different ways, 
such as stretch activated ion channels, calcium channels (Ca
2+), gap-junctions and 
integrin interaction with the matrix (Banes et al., 1995; rev Wall & Banes, 2005). 
In human tendon cells an early response with an increase of intracellularly Ca
2+ 
has been reported (rev Wall & Banes, 2005). Calcium-ions act as an intracellular 
messenger in many signal-transducing pathways, which induces transcription of 
certain genes. In addition, calcium-ions can pass through Gap-junction into other 
cells propagating the signal and response in the tissue. The activated/stimulated 
tenocytes start to synthesize new matrix components for the ECM and DNA-
synthesis indicating mitotic activity (Banes et al., 1995). Inactivity, 
immobilization or stress-shielding reduces the tendon strength and give a 
deterioration of the matrix (Yasuda & Hayashi, 1999). This indicates that loading 
is necessary to stimulate the tenocytes to sustain the tendon-ECM. However when 
the load exceeds a certain threshold, the wear (represented by breaking of links 
and bonds within the matrix) cannot be compensated. 
 
Tendon injuries 
The terminology of tendon disorders and tendon injuries is confusing. 
Tendinopathy, tendinosis, tendonitis, paratenonitis, tenosynovitis, tenovaginitis 
and peritendinitis are all labels used for diagnoses, though the definition of each   19 
remains unspecified (Josza & Kannus, 1997). They appear to be used differently 
by equine practitioners, radiologists, and pathologists. To summarize; 
Tendinopathy - is a diagnosis that includes all non-specific pathologic changes in 
the tendon, and has been used when degeneration of the ECM is found in the 
tendon without inflammation (Maffulli, Khan & Puddu, 1998; rev Kjaer, 2004). 
Tendinosis - (previously defined as tendinits) is used similarly to tendinopathy, for 
degeneration showing no clinical or histological signs of intratendinous 
inflammation (Josza & Kannus, 1997a; Maffulli, Khan & Puddu; 1998, Kahn et al 
2002). 
Tendinitis - can be defined as manifest inflammation in the tendon including 
inflammatory cells. An inflammation will always be present in connection with 
acute rupture (total or partial) characterized by collagen necrosis, haemorrhaging 
and inflammatory oedema (Josza & Kannus, 1997a). 
Tenosynovitis, tenovaginitis and peritendinitis all come under the definition of 
paratenonitis. These are characterized by the presence of inflammatory cells in 
paratenon or peritendinous areolar tissue. 
Tendon injury ranges in severity from small partial fibre rupturing to complete 
rupture of the tendon (Goodship, 1993). The rupture is caused by overstrain or 
percutaneous insult. Overstrain injuries have two aetiologies: 1) sudden impact or 
load that exceeds the resistive strength of the tendon tissue, or 2) degenerated 
tendon tissue that has lost its normal tensile strength with rupture occurring under 
a 'normal' load (Davis & Smith, 2006). 
High cyclic load alone has been suggested to cause collagen fibril degeneration. 
That is, repeated high load causes small ruptures in the fibril structure, tenocytes 
cannot replace the ruptured tissue, leading to slow degradation (wear and tear) of 
the tissue. During the stride, tendons experience load so the tenocytes respond 
with increased metabolic activity (Langberg et al., 2001). Tensional loading 
(defined as running) stimulates the cells to repair and restore injured and damaged 
structures in the ECM of the Achilles tendon (Langberg et al., 2001). When this 
wear and tear proceeds faster than the repair and replacement processes, the 
tendon will lose structural integrity; it will degenerate and, therefore can rupture 
(Fackelman, 1974; Benjamin & Ralphs, 1997). 
During cyclic load, as in galloping, some of the kinetic energy is lost and 
transformed into heat. This raises the temperature (42-44° C) in the tendon, which 
cannot be transported away due to a relatively limited blood supply (Wilson & 
Goodship, 1994). High temperatures affect the tenocytes, altering metabolic 
activity, and so decreasing their ability to repair ECM. In addition, stress promotes 
an uncontrolled release of proteolytic enzymes, such as MMPs. Under normal 
conditions these remove damaged or old structures in the ECM. The uncontrolled 
enzyme release degrades the ECM regardless whether it is damaged or not. The 
cells are unable to compensate for this increased tissue damage and the ECM starts 
to degenerated (early aging). 
Microscopic degenerative changes have been reported in tendons from horses 
without any clinical sign of tendon injury (Webbon, 1978). The same type of 
histological changes can be seen near the rupture in newly ruptured human 
Achilles tendons (Eriksen et al., 2002; Jozsa & Kannus, 1997b). This suggests that 
degeneration precedes the rupture. The degradation process is probably an 
inevitable aging process, but there are reports suggesting that the speed of the   20
degeneration can be altered (increased/decreased) by using certain types of 
training regimes (Smith et al., 2002). Furthermore, training during growth should 
be optimized to obtain the highest possible physiological properties in the tendon 
(Smith et al., 2002). 
After rupture, most often partial, an acute bleeding with oedema and an 
inflammatory response follows. The repair process starts with fibroblasts 
becoming activated and migrating into the damaged area. Fibroblasts produce type 
III collagen fibrils to bridge the rupture. These fibrils are then slowly replaced by 
collagen type I fibrils, but the orientation of these fibrils is often not strictly linear, 
thereby reducing the tendon's elasticity (Davis & Smith, 2006). 
Both increased vascularization and loss of vessels might be involved in the 
pathogenesis of equine flexor tendon and human Achilles tendon pathology 
(Strömberg & Tufvesson 1969; Pufe et al., 2005). In the Achilles tendon, 
degenerative changes most commonly emerge in areas that have poor 
vascularization (Josza & Kannus, 1997b; Petersen et al., 2005). The avascular 
tendon tissue is thought to be predisposed to degenerative tendon disease after 
findings of increased lactate levels during exercise in human achilles (Alfredsson 
et al., 2002) and/or the hypothermia (42-44°C) reported in horse tendons during 
high-speed training (Wilson & Goodship, 1994). In contrast to this, 
neovascularization (detected with Doppler and ultrasound) has been reported in 
Achilles tendons with chronic pain (Öhberg, Lohrentzon & Alfredson, 2001). 
Similar vascular changes have been found in horses with chronic tendon problems 
(Kristoffersen et al., 2005). Two of the growth factors that stimulate endothelial 
cell proliferation are vascular endothelial growth factor-1 and 2 (VEGF-1 and 2). 
VEGF-1 and 2 also stimulates both endothelial cells and tenocytes to produce and 
release MMPs that degrade the ECM further. 
The mechanism of neovascularization is not clear but it is induced by several 
growth factors and cytokines released from the hypoxic/hyperthermic/avascular 
tissue. These stimulate the endothelial cells to proliferate and migrate into the 
degenerative area where neovascularization is triggered by VEGF-1 and VEGF-2 
(Pufe et al., 2005). 
 
Treatment of equine tendon injury 
In current therapies of tendon injuries (ruptures) the primary object is to minimize 
the haemorrhages and inflammation using pressure, cold bandages and anti-
inflammatory drugs (Dyson 2004; Davis & Smith 2006). Then focus is on the 
repair and remodelling period optimize the type I collagen synthesis and alignment 
of the fibrils without creating an irregular vascularized scar tissue. Several 
strategies have been proposed including intratendinous injections with hyaluronan, 
polysulphated glycosaminoglycans (PS-GAG), beta-aminopropionitrile fumarate 
(BAPN) and the almost ancient surgical splitting of the tendon (Davis & Smith 
2006). 
PS-GAG has been proposed mainly because of its ability to inhibit collagenase 
and macrophage activation (Dowling et al., 2000). In addition, PS-GAG has been 
suggested to stimulate the synthesis of collagen in the tendon (Dowling et al., 
2000). Hyaluronan treatment of acute tendon is thought to have similar functions 
as PS-GAG with anti-inflammatory properties and to reduce adhesion between the   21 
injured tendon and the surrounding tissue. However, scientific results confirming 
these theories are absent or weak and collagenase-induced tendon lesions treated 
with hyaluronan showed no significant benefit from this treatment (Foland et al., 
1992). 
BAPN is a substance inhibiting the hydroxylation of lysine by binding to the 
lysyloxidase enzyme (Stryer, 1988). Lysyloxidase is an essential enzyme in the 
formation of intra- and intermolecular cross-links in the collagen fibril. This 
makes the collagen fibrils less resistant to degradation, which theoretically 
increases turnover. This facilitates the remodelling of the repair tissue, and results 
in better aligned collagen fibre structures. 
Tendon splitting is another treatment of tendon and ligament injuries in horses first 
described by Gerhard Forssell, later modified by Åsheim (Åsheim, 1964; 
Strömberg, Tufvesson & Nilsson 1974). The injured part of the tendon/ligament is 
divided by a single longitudinal incision, which allows in growth of vessels. These 
vessels were thought to promote healing and connective tissue synthesis 
(McCullagh, Goodship & Silver, 1979). Nowadays, tendon splitting is used in 
acute core lesions with presence of hematoma or oedema (Dowling et al., 2000) to 
reduce the pressure and hamper compartment formation (Davis & Smith 2006).  
In a study by Dyson (2004) BAPN, PS-GAG and hyaluronan injections were 
compared with the conservative treatment, including acute NSAID treatment 
followed by a rehabilitation programme with slowly increasing activity and 
repetitive monitoring with clinical examination and ultrasound. BAPN treated 
tendons had a better alignment of the ultrasound structure and a lower reinjury rate 
compared with PS-GAG and the conservative method. However, when reinjury to 
the untreated limb was considered the rate of reinjury rose to ~40% in the BAPN 
treated horses, and the four treatments did not differ significantly. 
BAPN-, PS-GAG, hyaluronan-injections as well as tendon splitting all aim at a 
repair- and remodelling-process with the end result of a functional scar. However, 
the difference between the treatments and conservative management is minimal 
(Dyson 2004). 
In recent years, another approach has been introduced on tendon injuries in order 
to optimize the repair; growth factors and stem cells are used to induce normal 
tendon tissue formation in the lesion area. Growth factors such as insulin-like 
growth factors 1 and 2 (IGF-1, 2) and fibroblast growth factor (FGF) have been 
used experimentally (in vitro) on tendon explants. An increased synthesis of type I 
collagen and other ECM -compounds was observed. In a study performed on 
collagenase induced tendon injuries in horses, treatment with IGF-1 decreased the 
soft tissue swelling and increased the DNA and collagen synthesis (Dahlgren et 
al., 2002). 
Clinically, different “mixtures / brands” are injected into the injured tendon (such 
as; urinary bladder matrix (UBM) also known as A-cell) which, according to the 
manufacturer, contains several important factors that promotes a production of 
normal ECM. 
Adding stem cells to the injured tendon has also become a treatment that is used 
today (Smith et al 2003; Smith & Webbon 2005). Experimental studies on acute 
injury rabbit Achilles tendon (Young et al., 1998) and patellar tendon (Awad et 
al., 1999) showed new tendon-like tissue after stem-cell injection. However, there 
is little scientific validation of the treatment results on equine tendon injuries   22
(Smith et al., 2003; Smith & Webbon 2005). In brief, sternal bone marrow fluid is 
collected from the patient and then injected into the lesion. To reduce the risk of 
injecting harmful substances, such as bone fragments, a refined method has been 
developed, where stem cells are collected from the bone marrow and cultured for 
4-6 weeks. The cell suspension of fibroblastic cells is injected into the lesion 
(Smith et al., 2003; Smith & Webbon 2005).    23 
 
Aims of the thesis 
 
This thesis is designed to investigate the ultrastructural distribution of certain 
macromolecules (COMP, TSP-4, collagen I and III) within normal tendon with 
respect to their concentration in various extracellular compartments. More 
specifically, the study was also designed to evaluate the influence of age and 
physical activity on these molecules in the midmetacapal part of the equine 
superficial digital flexor tendon and rodent Achilles tendon. Finally, the thesis 
intended to describe the microscopic alterations and immunolocalization of 
COMP, TSP-4, type I and III collagens in equine tendons with chronic injuries. 
Increased understanding of tendon ECM and its response to activity, ageing, and 
injury is important in designing training programmes and treatment regimes for 




The hypotheses were: 
*    COMP levels increase in the SDFT from birth up to skeletal maturity, and 
increasing COMP levels are correlated to a higher amount of thin type I collagen 
fibrils.  
* TSP-4 is present in the equine tendon and has a similar distribution pattern as 
COMP. 
*    Running activity in rats increases COMP and TSP-4 in the Achilles tendon 
ECM. Activity also affects fibril thickness of type I collagen. 
* Scar tissue in chronic tendon injuries contains more type III collagen than 
normal tendons and additionally, COMP and COMP mRNA levels are higher in 
these regions. 
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Material and methods 
The first study (I) sampled from the superficial digital flexor tendon and deep 
digital flexor tendon in active horses (standard bred and thoroughbred) that had 
been euthanized for reasons other than tendon injury. Horses with no history of 
tendon problems showing no macroscopic or histological sign of tendon injuries 
were included in the study. Three mm cubes were collected from the 
midmetacarpal region of the tendons within 4 hours post mortem. The samples 
were fixed in a mixture of 3% paraformaldehyde and 0.1% glutaraldehyde in 0.15 
M cacodylate buffer with 3 mM CaCl2 pH 7.4 and stored at 4 °C. Specimens were 
then cryosectioned longitudinally as described by Hultenby and co-workers (1993) 
and embedded transversally for routine electron microscopy according to standard 
protocol (Gross et al., 2000). Parallel samples, 5 mm thick, were fixed in 4% 
phosphate buffered formaldehyde solution, pH 7.4 and used for light microscope 
evaluation and in situ hybridisation. 
 
The ultrathin cryosections were incubated with rabbit polyclonal antiserum to 
bovine COMP (1:400) (Hedbom et al 1992). The bound antibodies were detected 
with protein-A coated with 10 nm gold (Amersham, UK). Specimens were 
examined in a calibrated Leo 906 transmission electron microscope (TEM) 
(Oberkochen, Germany) at 80 kV. Five micrographs (approximately 67000 x 
magnifications) from both compartments (pericellular and interterritorial) in each 
specimen were analysed. The number of gold markers were examined in a Leo 
906 microscope, calculated on digital images using an automatic calculation 
program, KS 4.00 Software (Kontron, Germany) and expressed as gold markers 
per square micrometer (Au/µm
2). In addition, the distance from each gold marker 
to the closest dark-band was measured manually on printed micrographs (100,000 
x magnifications). The gold markers were grouped at distances of 0-16, 17-32, 33-
48, 49-64 nm, and displayed in a diagram. 
Fibril thickness was measured manually in each compartment using electron 
micrographs (three micrographs from each compartment) (x101000) on 
transversally cut specimens from every site. The fibrils were pooled into three 
groups according to thickness (0<60 nm, 60-150 nm and >150 nm) and displayed 
on histogram as percentage of the total number of fibrils. 
For in situ hybridisation, a cocktail of three oligonucleotide probes (32-35 mers) 
complementary to equine COMP mRNA was used. The probes were labelled at 
their 3´ end with digoxigenin-11-dUTP by using the DIG Oligonucleotide Tailing 
Kit (Roche, Mannheim, Germany). Sections from the paraffin embedded material 
were dewaxed, rehydrated and treated with Proteinase K (5 µg/ml; Roche, 
Mannheim, Germany). After acetylation with 0.25% acetic anhydride (Sigma) and 
prehybridisation the sections were overlaid with hybridisation solution containing 
5 pmol/ml of each probe and incubated overnight. Immunological detection of the 
bound probe was performed as described in the Non-radioactive in situ 
hybridization application manual by Boehringer Mannheim with slight 
modifications. The sections were examined with light microscopy and the 
intracellular marking was compared between the different age-groups.   25 
 
In the second study (II), fresh, front limb, midmetacarpal SDFTs were collected 
immediately after euthanasia from adult horses killed for non-orthopaedic reasons 
and stored at –20 °C until further processing. The tendon tissue material (200 g) 
was thawed, homogenized and extracted with a buffer containing EDTA. The 
extract was loaded to a DEAE-sepharose (Pharmacia) ion-exchange column. The 
protein rich fractions were collected and pooled. The pooled fractions were then 
loaded to a heparin-sepharose column. The bound proteins were eluted with a 
linear gradient of 0-1 M NaCl. The protein rich fractions were pooled and 
examined with SDS-PAGE and Western blot with antibodies against COMP and 
TSP-4. In addition, bands from a non-reduced gel were cut out and trypsin 
digested. The peptides in the digests were analysed with MS-MALDI TOF. The 
fractions were also subjected to two-dimension gel electrophoresis with non-
reducing conditions in the first gel followed by reduced conditions on the second. 
In addition, the sample was loaded to a protein-A agarose coupled to antibodies 
against COMP or TSP-4. After washing, the bound proteins were eluted and 
analysed with SDS-PAGE and Western blot. 
 
The third study (III) comprised Achilles tendons from 14 seven-week-old 
Sprague-Dawley female rats (Niehoff et al., 2004). The control group of five rats 
was housed in pairs in cages without treadmills. The other nine were housed 
individually in similar cages with a treadmill. Exercise was done voluntarily and 
the activity of each treadmill was monitored by a computer and the distances were 
displayed as kilometre. The active rats were divided into two groups, low running 
distance 27-36 km/week and high 56-92 km/week. After four weeks of activity the 
rats were anaesthetized, weighed and euthanized before the left Achilles tendon 
were collected and fixed in a 3% paraformaldehyde and 0.1% glutaraldehyde in 
0.15 M cacodylate buffer with 3 mM CaCl2 pH 7.4 and stored at 4 °C. 
The tendons were trimmed into ~1 mm cubes and subjected to cryo-sectioning as 
described by Hultenby and co-workers (1993). Briefly, the specimens were 
infiltrated with 2.3 M sucrose and frozen in liquid nitrogen. Sectioning was 
performed at –95 °C. Ultrathin longitudinal sections (100 nm) were placed on 
carbon coated formvar nickel grids, thawed and placed on drops on 0.15 M 
cacodylate buffer containing 0.1 M glycine followed by drops of 10% bovine 
serum albumin (BSA) to reduce non-specific background. Parallel samples were 
embedded transversally for routine electron microscopy according to a standard 
protocol (Gross et al., 2000). 
Parallel longitudinal ultrathin sections were incubated with a rabbit polyclonal 
serum against bovine COMP (1:100) (Hedbom et al., 1992) and a guinea-pig 
polyclonal serum against recombinant rat TSP-4 (1:50) (Narouz-Ott et al., 2000). 
The sections were thoroughly washed in the same buffer and the bound antibodies 
were detected with protein-A coated with 10 nm gold (Amersham, UK). The total 
gold markers was calculated in a Tecnai 10 microscope (FEI company, The 
Netherlands). Digital images were photographed with a Megaview III camera 
(Soft Imaging System, Münster, Germany) and calculations were done manually 
in Adobe© Photoshop 5.0.2 and expressed as gold markers per square micrometer 
(Au/µm2). The distance from each gold marker to the closest dark band was 
measured manually in Adobe© Photoshop 5.0.2 in a selected number of   26
micrographs. The gold markers were grouped at distances of 0-17, 18-33, 34-50 
and 51-67 nm and displayed in a diagram. 
Fibril thickness was measured manually on digital images using analysis software 
(Soft Imaging System, Münster, Germany). Mean fibril thickness was measured in 
each specimen in the pericellular and interterritorial compartment. In addition, 
fibrils were pooled into three groups small (0>60 nm), medium (60-150 nm) and 
large fibrils (>150 nm) and displayed as a percentage of the total number of fibrils 
in each individual representing fibril size distribution. 
In study IV, nine superficial digital flexor tendons were collected from horses (age 
5-25 years) euthanized due to chronic tendon injuries defined and localised with 
ultrasound scanning. As controls, three superficial digital flexor tendons from high 
performing horses (age 3-13 years) sent to necropsy for non-orthopaedic reasons 
were used. Thin 5-mm-slices of the midmetacarpal areas of the normal and injured 
tendons were obtained and fixed in a standard phosphate buffered 4% 
formaldehyde solution. After dehydration and paraffin embedding the specimens 
were sectioned longitudinally in 6 µm thick sections. Parallel sections were made 
from each specimen (including controls) and incubated with antibodies against 
type I and III collagen and COMP. Staining with haematoxylin & eosin (H&E) 
and Masson-Trichrome was also performed and in situ hybridisation for COMP 
mRNA (described in paper 1) was done. Each specimen was morphologically 
described and the structures were classified into: normal aligned fibres, 
fibroblastic organized tissue, fibroblastic disorganized tissue, endotenon, necrosis 
and haemorrhages. The area of each structure was estimated using a morphometric 
grid (10*10) and displayed as percentage of the total section area. The 
immunostaining were graded between 0-3 where 0=no staining and 3=strong and 
widespread staining in every structure. The amount of cells with positive 
intracellular staining for COMP mRNA was calculated in the different structures, 
in each section, and graded as 0, 1, 2 and 3, with 0 representing no positive cells 




COMP in SDFT from normal horses (papers I and IV) 
Immunolabelling for COMP in the SDFT showed low levels in foetuses and foal 
and a more than two fold increase in three-year-old horses (paper I). These 
findings agreed with those for in situ hybridisation of COMP. The highest 
expression of COMP mRNA was confined to the tenocytes in the central part of 
the SDFT from three-year-old horses. The tendon from foetuses did not express 
any COMP mRNA (paper I). Immunollabeling for COMP and expression of 
COMP mRNA in SDFT from adult horses (3, 3, 13 years old controls, paper IV) 
under light microscopy were located exclusively in the fibre bundles with no 
staining in the endotenon.   27 
COMP and TSP-4 in normal equine SDFT (paper II) 
In an extract of normal equine superficial digital flexor tendons, COMP and TSP-4 
could not be separated under non-reducing conditions. This close association 
between COMP and TSP-4 implicated further studies that revealed unique 
heterooligomersation between COMP and TSP-4 in the equine tendon. 
 
Collagen type I fibril thickness in the SDFT from normal horses (paper I) 
The distribution of fibrils into thin, medium and thick differed between age 
groups, showing an increase in the relative number of thin fibrils in tendons from 
older horses. In addition, the fibrils in tendons from foetuses had a homogenous 
fibril population, with few thick and thin fibrils. 
 
COMP, TSP-4 and type I collagen fibrils in Achilles tendon from active 
rats (paper III) 
The immunolabelling for COMP was significantly lower in Achilles tendon from 
rats in the two active groups compared to the control group. These tendons did not 
show any difference in COMP immunolabelling in the interterritorial as compared 
to the pericellular compartments. 
 
The immunolabelling for TSP-4 was generally higher in the pericellular 
compartments compared to the interterritorial compartments of the Achilles 
tendons. However, no difference was recorded between the active and control 
groups. The location of gold markers for COMP and TSP-4 was accentuated at the 
dark bands of the collagen fibril, representing the gap region.  
In the pericellular compartment, a higher amount of small fibrils was recorded in 
the tendon of active rats compared to the controls.  
 
Immunolocalization of COMP, type I and III collagens in the injured 
equine tendon (paper IV) 
In all the normally aligned structures including the controls, there was a clear 
immunostaining for type I collagen as well as COMP. Also, the expression of 
COMP mRNA was strong in the fibre bundles. The endotenon exhibited no or 
weak immunolabelling for type I collagen and COMP, instead immunoreactivity 
for collagen type III was evident. 
 
Immunostaining for COMP was most prominent in the normal aligned structures 
in the injured tendons. The endotenon of the injured tendon was mostly unstained 
for COMP and lacked expression of COMP-mRNA in most cells. Fibroblastic, 
organized and disorganized structures showed a mild to moderate intensity of the 
immunolabelling for COMP in most of the tendons. 
Most fibroblastic structures, both organized and disorganized, were 
immunostained for type I collagen. All sections of injured tendons were to some 
degree immunolabelled for type III collagen. However, the pattern differed 
between controls and injured tendons where immunolabelling in the controls was 
restricted to the endotenon areas. The injured tendon displayed immunostaining 




The extracellular matrix in the equine tendons changes with age and activity with 
subsequent alterations of the physical properties present (Birch et al., 1999a, Birch 
et al., 1999b). These changes might be a physiological adaptation to load, but can 
result in a degenerative process (Smith et al., 2002) that weakens the tendon. The 
degeneration predisposes the tendon to micro tears, and partial and total ruptures 
with an acute inflammatory reaction followed by repair and remodulation. The 
aethiopathogenesis of this degeneration is not clear but local hyperthermia, 
hypoxia and cyclic high load alone or in combinations have been proposed as 
possible causes (Goodship, 1993; Wilson & Goodship, 1994).  
In this thesis, COMP and its relation to TSP-4, type I collagen fibrils and variation 
with age and exercise is studied. The distribution of COMP, type I and III 
collagens in the different structures present in repair tissue of injured tendons are 
also investigated. 
 
COMP, TSP-4 and Collagen in normal horses 
Previous studies report an increase of COMP in equine flexor tendon with load 
and maturation (Smith et al., 1997). Changes in COMP related to activity have 
been reported, with a decrease in COMP after an 18-months exercise programme 
(Smith et al., 2002). COMP has also been proposed as a biomarker for tendon 
injury (Smith & Heinegård, 2000). The results from the first study (I) with high 
immunogold labelling in superficial digital flexor tendons from three-year-old 
horses support these data. In the same study an increase in the relative amount of 
thin type I collagen fibrils in tendons from the three-years-old horses were 
observed. This change in fibril pattern, also observed in other studies 
(Cherdchutham et al., 2001) can be an early sign of degeneration, fibril splitting, 
or an adaptation to load with increased synthesis of new, thin fibrils. This can be 
included in the normal maturation process or be interpreted as result of micro 
trauma. A decrease of the mean fibril thickness in the central core of the SDFT in 
horses after commencing an 18-months training programme has been reported 
(Patterson-Kane  et al., 1997) and this decrease was interpreted as possible 
evidence of micro trauma. 
The cause of the increase in COMP is not clearly stated. Either it could be a result 
of normal growth/ageing/maturation or it could be a result of the longer 
accumulated activity, present in the equine athletes. The results in Paper I suggest 
that COMP is related to the increase in amount of thin collagen fibrils. If the 
presence of small fibrils in the tendon is a sign of micro trauma, the connection 
with high immunolabelling for COMP may suggest COMP as a biomarker for 
overuse in tendons. 
The presence of TSP-4 in bovine tendons was reported by Hauser and coworkers 
(1994). Its structural resemblance to COMP suggested a similar function. In Paper 
II the aim was to purify TSP-4 from equine tendon to produce antibodies for 
further ultrastructural investigations. However, TSP-4 could not be separated from   29 
COMP in the equine tendon, under non-reducing conditions. In vitro studies on 
COMP and TSP-4 (Hecht et al., 1998) suggest a possible heterooligomerization 
between COMP and TSP-4. Our results revealed for the first time that COMP and 
TSP-4 form oligomers in vivo in the equine tendon. The addition of a TSP-4 
subunit into the COMP -bouquet adds heparin-binding properties with abilities to 
interact with cell surfaces. Heterooligomeres of COMP/TSP-4 have not been 
found in other tissues, such as cartilage. Hence, this may be used to determine 
whether the COMP molecules found in serum originate from ECM of cartilage or 
tendon. 
 
COMP, TSP-4 and Collagen fibrils in active rats 
To further investigate the influence of activity on ECM-structural molecular 
composition rats were used in an experimental model, where the running distance 
in a treadmill of each rat was monitored (Paper III). After four weeks of voluntary 
running, the rats were sacrificed and the Achilles tendons were analysed for 
immunolcalization of COMP, TSP-4 and collagen fibril diameter at ultrastructural 
level. The results did not confirm our hypothesis that COMP would increase with 
activity; however, an alteration of molecular set up was found with lower 
immunolabelling of COMP in tendon from active rats compared to controls. This 
could either be explained with species differences (rat vs. horse), different tendons 
(Achilles vs. SDFT) or the short period of load combined with the use of skeletal 
immature individuals (the rats were only three weeks old when the experiment 
started). 
There were significant higher amounts of thin fibrils in the pericellular area of the 
tendon from the active rats compared to the controls. This increase of thin fibrils 
might be an indication of synthesis, but can also be caused by splitting or 
degradation of collagen. In addition to COMP, we also delineated the 
immunolabelling of TSP-4 that is structurally related to COMP. TSP-4, like 
COMP, has collagen binding properties. However, unlike COMP it has an 
additional heparin-binding domain in the N-terminal. This heparin-binding domain 
adds cell-binding properties suggesting TSP-4 as an interface molecule between 
the tenocytes and the extracellular matrix. The ultrastructural immunolocalization 
of TSP-4 was highest in the pericellular compartment with a marked localization 
to the fibrils next to the cell membrane. Moreover, the majority of gold markers 
representing both COMP and TSP-4 were located at the dark-bands of the 
collagen fibril representing the gap-region. This suggests the same binding sites on 
the collagen fibril and/or co-localization (i.e. heterooligomerization).  
 
COMP, type I and III Collagens in the injured equine tendon 
In Paper IV, injured equine SDFT, where the lesions were defined and localized 
with ultrasound scanning, were examined on light microscopic level. The 
immunolocalization of COMP, and type I and III collagens was delineated with 
reference to normal and pathologic areas in the tendons. The sections were 
morphologically characterized and the areas of the different structures (normal and 
pathologic) were estimated. In addition, the immunostaining of the different 
structures were evaluated and scored form 0-3 (0=no positive staining at all and 
3=strong positive staining).    30
The type III collagen fibrils have a thinner diameter than type I (Birk & Mayne, 
1997) and lower tensile strength. Increase of type III collagen has been reported in 
the early phase of repair after experimentally induced tendon lesion (Dahlgren, 
Mohammed & Nixon, 2005). The presence of type III collagen in the fibroblastic 
areas (Paper IV) indicates such a repair process. In ruptured human Achilles 
tendons, an increase of type III collagen fibrils have been reported (Eriksen et al., 
2002). Type III collagen were also found in acellular areas, which suggests that 
type III collagen is involved in the degenerative process as described in the human 
Achilles tendons (Eriksen et al., 2002; Mafulli & Kader, 2002). 
Adult mesenchymal stem cells are present as reservoirs in various tissues of the 
body. Stem cells are found in the bone marrow but there are also tissue stem cells, 
located in different sites called niches outside the bone marrow (Kumar, Abbas & 
Fausto, 2005). Stem cells retrieved from the bone marrow injected into the injured 
tendon are thought to differentiate into tenocytes or fibroblasts with tenocytic 
properties (Smith et al., 2003). These cells could then aid in the repair of the 
lesion by production of ECM molecules that resembles the original ECM of a non-
injured tendon. However, scientific data for this hypothesis are sparse. The results 
in Paper IV do not indicate a lack of fibroblasts/tenocytes as a key mechanism in 
tendon healing. The high number of fibroblastic cells found in the injured tendons 
(Paper IV) shows that cells are already present in the tendon. These cells, probably 
originating from the endotenon and surrounding paratenon, migrate into the 
degenerated areas where they proliferate and differentiate into more tenocyte-like 
cells. However, it is not possible to differentiate between the fibroblast and the 
tenocyte in the present study. Previous studies suggest that tensional load is 
necessary for a tenocytic differentiation of the mesenchymal cells (Banes et al., 
1999; Tsuzaki et al., 2005). Irrespective of the origin of the cells in the lesion 
(implanted, migrated or other) load is necessary to stimulate the synthesis of ECM 
-molecules needed for restoring the tendon properties. 
 
The clear presence of COMP (immunolabel and mRNA expression) in the 
fibroblastic areas indicates that COMP is involved in the repair and remodelling 
processes of the collagen fibrils in the ECM. The COMP molecule has been 
suggested to enhance the fibrillogenesis. In accordance to the present results with 
increased COMP in the repair/healing tendon, previous studies report increased 
levels of COMP in synovial fluid from horses with injured tendons (Smith & 
Heinegård, 2000). In addition, dermal fibroblasts from Scleroderma patients 
express COMP, which is not found in normal skin fibroblasts (Farina et al., 2006). 
Scleroderma or systemic sclerosis is characterized by abnormal accumulation of 
fibrous tissue, dominated by type I collagen, in skin and other organs (Abbas, 
2005). The presence of COMP indicates a role in the collagen fibrillogenesis in 
the repair process. In accordance with this and previous findings, COMP might be 
a possible biomarker for injury and repair in the equine tendon. 
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Conclusions 
The ultrastructural immunolocalization of COMP together with the COMP mRNA 
expression in equine superficial flexor tendon suggest an increase in synthesis and 
presence of COMP during maturation (until three-years of age). In addition, the 
relative number of thin fibrils increases with age/maturation, up to three years of 
age, in the equine tendon. The higher quantity of thin fibrils indicates either novel 
synthesis or degradation of the collagen fibrils. 
TSP-4 and COMP form heterooligomeres in the equine superficial digital flexor 
tendon. This unique molecule may be a marker candidate for tendon metabolism. 
Four weeks of voluntary activity decreases immunolabelling of COMP in Achilles 
tendons from young rats and the collagen fibrils in the pericellular compartments 
are thinner compared with fibrils in the interterritorial compartments in the active 
rats indicating synthesis or degradation. Moreover, the ultrastructural 
immunolocalization of TSP-4 was clearly elevated in the pericellular 
compartments compared with the interterritorial compartment in tendons from rats 
in both the control and exercise groups, indicating a role as interface molecule 
between the cell surface and the ECM. 
Immunolabelling of COMP and type III collagen in injured equine tendons was 
marked in the fibroblastic repair tissues. The marked presence in repair tissue 
suggests a role for COMP in the remodelling/organisation of the scar tissue.  
 
Future perspectives 
The present thesis has focused on some important extracellular matrix proteins 
present in the tendon. The relationship between COMP, thin fibrils and activity 
must be further investigated in the equine athlete. The presence of heterooligomers 
between COMP and TSP-4, i.e. the relation within the heterooligomer and 
whether there are pure pentamers of TSP-4 in the equine tendon needs further 
attention. The unique heterooligomeres of COMP and TSP-4 may have a specific 
function in the tendon and therefore, be important in tissue healing. The 
heterooligomer can also help distinguishing the origin of COMP-residues in 
serum. 
In addition, injured tendons should be characterized with an extended battery of 
antibodies where antibodies should be used against VEGF-1 and –2, TSP-4, and 
small proteoglycans such as decorin, fibromodulin, biglycan, involved in the 
regulatory processes in collagen fibrillation.  
These studies should be done with the aid of ultrasound imaging, light and 
electron microscopy to characterize the normal and injured tendon tissue. These 
types of studies should concentrate on tendon repair where complete healing is 
achieved, to find the key mechanisms behind healing. This knowledge will aid in 
better treatments of tendon injury without scar formation, which often has an 
impaired tensile strength and is prone to adhesions and reinjury. 
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